Solid state forms of racemic ilaprazole
    1.
    发明授权
    Solid state forms of racemic ilaprazole 有权
    外消旋伊拉唑的固体形式

    公开(公告)号:US08592600B2

    公开(公告)日:2013-11-26

    申请号:US12939276

    申请日:2010-11-04

    IPC分类号: C07D401/12

    CPC分类号: C07D401/14

    摘要: The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.

    摘要翻译: 本发明涉及外消旋的伊拉唑,2 [[(4-甲氧基-3-甲基-2-吡啶基) - 甲基]亚磺酰基] -5-(1H-吡咯-1-基)1H-苯并咪唑的结晶形式。 本发明还涉及用于抑制胃酸分泌的药物组合物,其包含有效抑制胃酸分泌的量的本发明的伊拉唑结晶形式和药学上可接受的载体。 本发明还提供了治疗各种酸相关胃肠道(GI)障碍的方法。

    Solid state forms of racemic ilaprazole
    2.
    发明授权
    Solid state forms of racemic ilaprazole 有权
    外消旋伊拉唑的固体形式

    公开(公告)号:US07999110B2

    公开(公告)日:2011-08-16

    申请号:US11966868

    申请日:2007-12-28

    IPC分类号: C07D401/14

    CPC分类号: C07D401/14

    摘要: The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2 -pyridinyl)-methyl]sulfinyl]-5-(1 H-pyrrol-1-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.

    摘要翻译: 本发明涉及外消旋伊拉唑,2 [[(4-甲氧基-3-甲基-2-吡啶基) - 甲基]亚磺酰基] -5-(1H-吡咯-1-基)1H-苯并咪唑的结晶形式。 本发明还涉及用于抑制胃酸分泌的药物组合物,其包含有效抑制胃酸分泌的量的本发明的伊拉唑结晶形式和药学上可接受的载体。 本发明还提供了治疗各种酸相关胃肠道(GI)障碍的方法。

    Solid state forms of racemic ilaprazole
    3.
    发明授权
    Solid state forms of racemic ilaprazole 有权
    外消旋伊拉唑的固体形式

    公开(公告)号:US08592599B2

    公开(公告)日:2013-11-26

    申请号:US12939266

    申请日:2010-11-04

    IPC分类号: C07D401/12

    CPC分类号: C07D401/14

    摘要: The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl)1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.

    摘要翻译: 本发明涉及外消旋的伊拉唑,2 [[(4-甲氧基-3-甲基-2-吡啶基) - 甲基]亚磺酰基] -5-(1H-吡咯-1-基)1H-苯并咪唑的结晶形式。 本发明还涉及用于抑制胃酸分泌的药物组合物,其包含有效抑制胃酸分泌的量的本发明的伊拉唑结晶形式和药学上可接受的载体。 本发明还提供了治疗各种酸相关胃肠道(GI)障碍的方法。

    Crystalline forms of solvated ilaprazole
    4.
    发明授权
    Crystalline forms of solvated ilaprazole 失效
    溶剂化伊拉唑的结晶形式

    公开(公告)号:US07989632B2

    公开(公告)日:2011-08-02

    申请号:US11966896

    申请日:2007-12-28

    IPC分类号: C07D401/12

    CPC分类号: C07D401/14

    摘要: The invention relates to crystalline forms of various solvates of ilaprazole, 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl)1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising crystalline ilaprazole hydrate according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.

    摘要翻译: 本发明涉及伊拉帕唑,2 [[(4-甲氧基-3-甲基-2-吡啶基) - 甲基]亚磺酰基] -5-(1H-吡咯-1-基)1H-苯并咪唑的各种溶剂合物的结晶形式。 本发明还涉及用于抑制胃酸分泌的药物组合物,其包含有效抑制胃酸分泌的量的本发明的结晶伊拉拉唑水合物和药学上可接受的载体。 本发明还提供了治疗各种酸相关胃肠道(GI)障碍的方法。

    NOVEL FORMS OF REBOXETINE
    9.
    发明申请
    NOVEL FORMS OF REBOXETINE 审中-公开
    新形式的复方

    公开(公告)号:US20100069389A1

    公开(公告)日:2010-03-18

    申请号:US12553564

    申请日:2009-09-03

    CPC分类号: C07D265/30

    摘要: The invention relates to novel crystalline forms of (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine hydrochloride. In various embodiments, the novel crystalline forms may be substantially enantiopure. The preparation and characterization of the novel crystalline forms of (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine hydrochloride is also described. The invention also relates to pharmaceutical compositions containing novel crystalline forms of (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine hydrochloride, which are useful to treat and/or prevent various conditions such as nervous system and pain disorders.

    摘要翻译: 本发明涉及(2R)-2 - [(R) - (2-乙氧基苯氧基) - 苯基甲基]吗啉盐酸盐的新结晶形式。 在各种实施方案中,新的结晶形式可以是基本上对映体纯的。 还描述了(2R)-2 - [(R) - (2-乙氧基苯氧基) - 苯基甲基]吗啉盐酸盐的新结晶形式的制备和表征。 本发明还涉及包含(2R)-2 - [(R) - (2-乙氧基苯氧基) - 苯基甲基]吗啉盐酸盐的新结晶形式的药物组合物,其可用于治疗和/或预防各种病症如神经系统和 疼痛障碍

    Web forum crawling using skeletal links
    10.
    发明授权
    Web forum crawling using skeletal links 有权
    使用骨架链接的网页论坛抓取

    公开(公告)号:US08099408B2

    公开(公告)日:2012-01-17

    申请号:US12163895

    申请日:2008-06-27

    IPC分类号: G06F7/06 G06F17/30

    CPC分类号: G06F17/30864

    摘要: A method and system for identifying informative links of a web site for use in crawling the web site is provided. A forum crawler analyzes sample web pages of a web forum to identify informative links and then crawls the web forum by following links determined to be informative and not following other links. The forum crawler system determines whether links are informative based on whether they are part of the overall structure of the web site or are used to select sequential information that has been split onto multiple web pages.

    摘要翻译: 提供了一种用于识别用于爬行网站的网站的信息链接的方法和系统。 论坛搜寻器分析网页论坛的示例网页,以识别信息链接,然后通过确定为信息而不是遵循其他链接的链接抓取网页论坛。 论坛搜寻器系统基于它们是网站的整体结构的一部分还是用于选择分割到多个网页上的顺序信息来确定链接是否具有信息性。